JameelMuzaffarMD

Endocrine Cancer, Head & Neck Cancer

Assistant Member and Clinical Assistant Professor, Moffitt Cancer Center

Dr. Muzaffar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

PubMed

7 citations
Unilateral conjunctival AL kappa amyloidosis with trace evidence of systemic amyloidosis.
Al-Ola Abdallah, Christopher T. Westfall, Harry H. Brown, Jameel Muzaffar, Shebli Atrash
The American Journal of Case Reports. 2012-06-06
55 citations
Diffusion-weighted magnetic resonance imaging for residual and recurrent cholesteatoma: a systematic review and meta-analysis.
Jameel Muzaffar, Christopher Metcalfe, Steve Colley, Christopher Coulson
Clinical Otolaryngology. 2017-06-01
13 citations
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma.
Xuefeng Wang, Jameel Muzaffar, Kedar Kirtane, Feifei Song, Matthew Johnson
Journal for Immunotherapy of Cancer. 2022-06-01

Lectures

A phase II study of capecitabine (Cape) or 5-fluorouracil (5-FU) with pegylated interferon alpha-2b (Peg-IFNA-2b) in unresectable/metastatic cutaneous squamous cell ca...
2019 ASCO Annual Meeting - 6/1/2019

Next-Generation Immunotherapy Drug Shows Continued Promise in Several Advanced-Stage CancersMay 26th, 2022